查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
介入性超音波市场-全球及区域分析：按应用、最终用户及区域-分析与预测（2025-2035）
市场调查报告书
商品编码
1798386

介入性超音波市场-全球及区域分析：按应用、最终用户及区域-分析与预测（2025-2035）

Interventional Ultrasound Market - A Global and Regional Analysis: Focus on Application, End User, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 134 Pages | 商品交期: 1-5个工作天内

价格

预计到 2024 年全球介入超音波市场规模将达到 22.387 亿美元。

预计到 2035 年，市场规模将快速成长至 42.237 亿美元，2025 年至 2035 年期间的复合年增长率将达到 6.05%。

主要市场统计数据
预测期 2025-2035
2025年评估 23.48亿美元
2035年的预测 42.237亿美元
复合年增长率 6.05%

这种稳定成长的驱动力源于人们对微创治疗日益增长的偏好、全球慢性病负担的不断加重，以及影像引导介入技术在心臟病学和肿瘤学等临床专科中的广泛应用。介入性超音波相较于传统治疗方式具有许多优势，包括即时导引、低辐射暴露和成本效益，使其在住院和门诊环境中都越来越具有吸引力。

造影超音波、弹性成像和基于人工智慧的自动化等技术创新正在进一步提高介入性超音波系统的准确性、易用性和诊断价值。然而，诸如对操作员的依赖性、影像品质参差不齐以及某些地区的报销挑战等限制因素可能会阻碍市场渗透。儘管存在这些障碍，但持续的研发投入、日益增长的临床应用以及对即时非辐射成像日益增长的需求预计将支持介入超音波市场的持续扩张。

市场介绍

介入性超音波市场正经历重大变革时期期，推动力来自持续的技术进步、策略性合作伙伴关係以及强调微创、即时、影像引导介入的不断扩大的临床应用。各公司正在将人工智慧、3D 成像、弹性成像和造影超音波整合到他们的平台中，以提高程式准确性和工作流程效率。通用电气医疗的 Versana Premier、佳能公司的 Aplio i 系列和西门子医疗股份公司支援人工智慧的介入性超音波系统等创新反映了这一趋势。策略性收购和研发投资正在进一步扩大产品系列加强市场占有率。随着超音波导引切片检查、肿瘤消融和血管通路手术越来越广泛的应用，介入超音波日益成为现代影像导引治疗方法的基石，为各种临床环境中提供精确、安全和无辐射的选择。

对产业的影响

全球介入超音波市场正经历临床实践的重大转变，这得益于各种治疗程序对即时无辐射成像解决方案日益增长的需求。佳能、百胜、通用电气医疗、荷兰皇家飞利浦和西门子医疗等行业领导者在推动介入性超音波技术发展方面发挥核心作用，该技术超越了传统的诊断应用，并支持精准引导介入。这些系统是肿瘤科、心臟科和急诊医学领域的重要工具，能够在最大程度减少患者创伤的同时实现针对性治疗。透过简化复杂的程序、减少对透视和CT的依赖，并提高门诊病人和资源匮乏地区医疗服务的可近性，介入性超音波有助于提高医疗服务的效率并改善手术效果。不断扩展的临床能力以及对全球微创和价值导向医疗趋势的支持，将进一步影响该市场。

市场区隔

细分一：按应用

  • 一般外科
  • 癌症
  • 心内和血管
  • 其他的

一般外科领域在介入性超音波市场占据主导地位（按应用）

从应用角度来看，全球介入性超音波市场将以一般外科手术为主导，到2024年将占据39.8%的市场。该领域占据主导地位的主要原因在于其广泛的临床效用以及微创手术系统的日益普及。介入性超音波在一般外科手术的应用日益广泛，用于即时引导切片检查、体液引流、肿瘤切除、血管通路等。它能够提供动态即时影像，无需放射线照射，使其成为术中决策和精准定位的理想选择。

细分 2：按最终用户

  • 医院和诊所
  • 门诊手术中心
  • 其他（用于研究目的）

医院和诊所部门主导介入性超音波市场（按最终用户）

从终端用户来看，医院和诊所将主导全球介入超音波市场，到 2024 年将占据 79.1% 的市场。医院和诊所凭藉其在提供先进、大容量和多学科介入治疗方面的关键作用，在终端用户介入超音波市场中占据主导地位。拥有最先进基础设施、熟练医疗专业人员和普通外科、肿瘤科、循环系统和急诊部科等专科部门的医院，最适合部署和利用介入超音波系统进行各种手术。这些系统能够在微创干预期间提供精确、即时的指导，这对于最终改善手术结果和缩短患者康復时间至关重要。医院和诊所投资下一代技术（如人工智慧整合和可携式超音波平台）的能力，进一步巩固了主导。此外，临床环境向门诊病人和日间护理环境的转变也加强了市场占有率，使医院和诊所成为全球介入性超音波应用的关键。

第 3 部分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

预计亚太地区介入超音波市场在预测期内将以7.06%的显着速度成长。这一强劲的成长轨迹受到多种因素的推动，包括医疗基础设施的快速发展、对微创手术的需求不断增长，以及即时成像技术在护理点的日益普及。亚太地区拥有一些技术最先进的医院和学术机构，尤其是在中国、日本、韩国和印度等国家，这些国家正在增加对精准医疗和影像引导治疗的投资。此外，该地区庞大的患者群体以及癌症、心血管疾病和肝病等慢性疾病盛行率的上升，正在推动各专业对介入性超音波的需求。

介入超音波市场的最新趋势

  • 2024 年 2 月，佳能宣布推出 Aplio Beyond，这是一款紧凑、环保的超音波诊断系统，整合了先进的成像功能和人体工学设计，可改善临床工作流程和患者照护。
  • 2025 年 1 月，GE HealthCare 的 Voluson Expert 系列超音波诊断设备（包括 Voluson Expert 22、20 和 18）获得了 FDA 510(k) 许可。 Voluson Expert 22、20 和 18 整合了先进的人工智慧功能、增强的影像处理工具和人体工学设计，可提高女性医疗保健（尤其是高风险怀孕）的工作流程效率和诊断准确性。
  • 2024 年 8 月，荷兰皇家飞利浦公司与 Carrion Clinic 合作，在 Crystal Spring Tower 的新心血管研究所安装了 11 间先进的介入套件。
  • 2024年4月，百胜集团将透过其子公司百胜亚太诊断私人有限公司在印度北方邦建立新的製造工厂，为当地市场生产先进的印度製造超音波诊断系统。该厂将提供MyLab A、MyLab E系列以及配备人工智慧增强洞察技术和创新触控萤幕控制的紧凑型可携式型号。

需求——驱动因素、挑战、机会

市场驱动因素

微创手术需求不断增长：微创手术需求不断增长是介入超音波市场的主要驱动力。微创手术透过提供优于传统开放性手术的独特优势（包括降低感染风险和显着缩短恢復时间）而改变医疗保健格局。据 Paragon 外科中心称，接受微创手术的患者可以在几天到几週内恢復正常活动，而开放性手术通常需要较长的恢復期。介入性超音波透过提供即时、无辐射成像，能够在切片检查、肿瘤切除和血管通路等手术过程中实现精确定位，在这一转变中发挥核心作用。这不仅可以最大限度地减少附带组织损伤，还可以提高手术的准确性和安全性。此外，随着全球慢性病负担的增加以及患者偏好转向更快、侵入性更小的治疗，介入​​性超音波系统预计将在各种临床环境中加速普及。

市场挑战

高成本：儘管先进介入超音波系统具有临床益处，但其高昂的成本仍然是其广泛应用的重大障碍，尤其是在成本敏感且资源有限的环境中。配备人工智慧驱动软体和造影功能的高阶超音波平台需要大量的资本投入，这使得小型诊所和公立医疗机构难以获得这些平台。此外，与程序相关的成本，例如一次性设备和持续维护，可能会进一步加剧医疗保健预算的压力。这些成本限制限制了在农村和服务欠缺地区的部署，因为这些地区获得先进诊断成像的机会已经有限。解决这些可负担性挑战对于在全球范围内更公平地应用介入性超音波技术至关重要。

市场机会

新兴市场扩张：新兴市场为介入性超音波市场提供了巨大的成长机会，这得益于医疗保健投资的增加、基础设施的改善以及人们对微创技术的日益重视。亚太地区、拉丁美洲和中东地区的医疗保健成本正在快速增长，慢性病负担也日益加重，这推动了对可扩展、经济高效的影像解决方案的需求。此外，各国政府和全球医疗保健组织为改善诊断和治疗工具的可近性所做的努力，正在加速介入超音波系统的普及。透过本地伙伴关係、培训计画和区域特定产品线来扩大影响力的市场参与企业，可以从这些快速成长的经济体尚未开发的潜力中获益匪浅。

产品/创新策略：全球介入超音波市场已根据应用、最终用户、地区等不同类别进行了广泛细分。这有助于读者清楚了解哪个细分市场占有最大份额以及哪个细分市场在未来几年可能会成长。

成长/行销策略：在主要发展中，新开发最为普遍，占 2021 年 1 月至 2025 年 5 月全球介入性超音波市场总发展量的约 58.1%。

竞争策略：全球介入超音波市场拥有大量现有参与者及其产品系列。本研究分析和描述的全球介入性超音波市场主要企业概况包括提供介入性超音波系统产品的现有参与者。

本报告研究了全球介入超音波市场，并提供了市场概述、应用、最终用户和地区的趋势以及参与市场的公司概况。

目录

执行摘要

第一章全球介入超音波市场：产业展望

  • 主要市场趋势
    • 影响分析
    • 将人工智慧整合到超音波系统中
    • 增加超音波系统产品的推出
  • 专利分析
  • 监管状况
    • 美国
    • 欧洲
    • 亚太地区
  • 定价分析
  • 市场动态
    • 市场驱动因素
    • 市场挑战
    • 市场机会

2. 全球介入性超音波市场（按应用），2023-2035

  • 一般外科
  • 癌症
  • 心血管医学
  • 其他的

3. 2023-2035 年全球介入性超音波市场（依最终用户划分）

  • 医院和诊所
  • 门诊手术中心
  • 其他的

4. 2023-2035 年全球介入性超音波市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第五章：竞争格局与公司概况

  • 竞争格局
  • 公司简介
    • Canon Inc.
    • DeepSight Technology, Inc.
    • Edan Instruments
    • Esaote SPA
    • FUJIFILM Holdings Corporation
    • GE HealthCare
    • Konica Minolta, Inc.
    • Koninklijke Philips NV
    • Samsung Healthcare
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Siemens Healthineers AG
    • SonoScape Medical Corp.

第六章调查方法

Product Code: BHR2914SA

This report can be delivered within 1 working day.

Introduction of Interventional Ultrasound Market

The global interventional ultrasound market, initially valued at $2,238.7 million in 2024, is projected to witness substantial growth, surging to $4,223.7 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 6.05% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$2,348.0 Million
2035 Forecast$4,223.7 Million
CAGR6.05%

This steady growth is being driven by the increasing preference for minimally invasive procedures, a rising global burden of chronic diseases, and the expanding use of image-guided interventions across clinical specialties such as cardiology and oncology. Interventional ultrasound offers several advantages over traditional modalities, including real-time guidance, reduced radiation exposure, and cost-effectiveness, making it increasingly attractive for both hospital and outpatient settings.

Technological innovations, such as the incorporation of contrast-enhanced ultrasound, elastography, and artificial intelligence-based automation, are further enhancing the precision, usability, and diagnostic value of interventional ultrasound systems. However, limitations such as operator dependency, variability in image quality, and reimbursement challenges in certain regions may constrain market penetration. Despite these barriers, ongoing R&D efforts, increasing clinical applications, and growing demand for real-time, non-radiative imaging are expected to support the sustained expansion of the interventional ultrasound market.

Market Introduction

The interventional ultrasound market has been undergoing significant transformation, driven by continuous technological advancements, strategic partnerships, and expanding clinical applications that emphasize minimally invasive, real-time image-guided interventions. Companies are increasingly integrating artificial intelligence, 3D imaging, elastography, and contrast-enhanced ultrasound into their platforms to enhance procedural accuracy and workflow efficiency. Innovations such as GE HealthCare's Versana Premier, Canon Inc.'s Aplio i-series, and Siemens Healthineers AG's AI-enabled interventional ultrasound systems reflect this trend. Strategic acquisitions and R&D investments are further broadening product portfolios and reinforcing market presence. As ultrasound-guided biopsies, tumor ablation, and vascular access procedures become more widely adopted, interventional ultrasound is increasingly positioned as a cornerstone of modern image-guided therapeutics, offering precision, safety, and radiation-free alternatives across diverse clinical settings.

Industrial Impact

The global interventional ultrasound market has been experiencing a notable shift in clinical practice, driven by growing demand for real-time, radiation-free imaging solutions across a wide range of therapeutic procedures. Industry leaders such as Canon Inc., Esaote SPA, GE HealthCare, Koninklijke Philips N.V., and Siemens Healthineers AG have been playing a central role in advancing interventional ultrasound technologies that support precision-guided interventions beyond traditional diagnostic applications. These systems are critical tools in oncology, cardiology, and emergency medicine, enabling targeted treatments with minimal patient trauma. By streamlining complex procedures, reducing reliance on fluoroscopy or CT, and enhancing access in outpatient and resource-limited settings, interventional ultrasound has been contributing to more efficient care delivery and improved procedural outcomes. The market's industrial impact is further amplified by its role in broadening clinical capabilities and supporting the global trend toward minimally invasive, value-based healthcare.

Market Segmentation:

Segmentation 1: by Application

  • General Surgery
  • Cancer
  • Cardiac and Endovascular
  • Others

General Surgery Segment to Dominate the Interventional Ultrasound Market (by Application)

Based on application, the global interventional ultrasound market was led by general surgery, which held a 39.8% share in 2024. The segment dominates the market primarily due to its broad clinical utility and increasing adoption of minimally invasive surgical systems. Interventional ultrasound is increasingly being used in general surgical procedures for real-time guidance in biopsies, fluid drainage, tumor ablation, and vascular access. Its ability to provide dynamic, real-time imaging without radiation exposure makes it an ideal modality for intraoperative decision-making and precision targeting.

Segmentation 2: by End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others (Research Use)

Hospitals and Clinics Segment to Dominate the Interventional Ultrasound Market (by End User)

Based on end user, the global interventional ultrasound market was led by the hospitals and clinics segment, which held a 79.1% share in 2024. Hospitals and clinics dominate the interventional ultrasound market based on end-users due to the pivotal role hospitals and large clinical centers play in delivering advanced, high-volume, and multidisciplinary interventional care. Equipped with state-of-the-art infrastructure, skilled healthcare professionals, and dedicated departments such as general surgery, oncology, cardiology, and emergency medicine, hospitals are ideally positioned to adopt and utilize interventional ultrasound systems for a wide range of procedures. These systems are essential for enabling precise, real-time guidance during minimally invasive interventions, ultimately improving procedural outcomes and reducing patient recovery times. The capacity of hospitals and clinics to invest in next-generation technologies, including AI-integrated and portable ultrasound platforms, further supports their leadership in this segment. Moreover, the increasing shift toward outpatient and day-care procedures within clinical settings continues to reinforce their market share, making hospitals and clinics the cornerstone of interventional ultrasound adoption globally.

Segmentation 3: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa

The interventional ultrasound market in the Asia-Pacific region is expected to witness a significant growth rate of 7.06% during the forecast period. This strong growth trajectory is driven by a combination of factors, including rapid advancements in healthcare infrastructure, rising demand for minimally invasive procedures, and the increasing adoption of real-time imaging technologies across surgical and diagnostic settings. Asia-Pacific is home to some of the most technologically advanced hospitals and academic institutions, particularly in countries such as China, Japan, South Korea, and India, where there is growing investment in precision medicine and image-guided therapies. Additionally, the region's large patient population and increasing prevalence of chronic conditions such as cancer, cardiovascular disease, and liver disorders have been fueling the demand for interventional ultrasound across a variety of specialties.

Recent Developments in the Interventional Ultrasound Market

  • In February 2024, Canon Inc. introduced the Aplio beyond, a compact, eco-friendly ultrasound system that integrates advanced imaging capabilities with ergonomic design, aiming to enhance clinical workflows and patient care.
  • In January 2025, GE HealthCare has received FDA 510(k) clearance for its updated Voluson Expert Series ultrasound systems, including the Voluson Expert 22, 20, and 18, which integrate advanced artificial intelligence features, enhanced imaging tools, and ergonomic design to improve workflow efficiency and diagnostic accuracy in women's healthcare, particularly for high-risk pregnancies.
  • In August 2024, Koninklijke Philips N.V. partnered with Carilion Clinic to equip the new Cardiovascular Institute at Crystal Spring Tower with 11 advanced interventional suites, integrating cutting-edge imaging and ultrasound technologies to enhance cardiovascular care and optimize clinical performance for complex procedures.
  • In April 2024, Esaote Group established a new manufacturing facility in Uttar Pradesh, India, through its subsidiary Esaote Asia-Pacific Diagnostic Private Limited, to produce advanced Made in India ultrasound systems for the local market. The site is expected to deliver the MyLab A, MyLab E series, and compact portable models, all featuring AI-powered augmented insight technology and innovative touchscreen controls.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Rising Demand for Minimally Invasive Procedures: The increasing demand for minimally invasive procedures is a key driver of the interventional ultrasound market. Minimally invasive techniques have been transforming the healthcare landscape by offering clear advantages over traditional open surgeries, including a lower risk of infection and significantly faster recovery times. According to Paragon Surgical Center, patients undergoing minimally invasive treatments can typically resume normal activities within days or weeks, compared to the extended recovery periods associated with open surgeries. Interventional ultrasound plays a central role in this transformation by providing real-time, radiation-free imaging that allows for precise targeting during procedures such as biopsies, tumor ablations, and vascular access. This not only minimizes collateral tissue damage but also enhances procedural accuracy and safety. Further, as the global burden of chronic conditions rises and patient preferences shift toward quicker and less invasive treatments, the adoption of interventional ultrasound systems is expected to accelerate across diverse clinical settings.

Market Challenges

High Cost of Equipment and Procedures: Despite its clinical benefits, the high cost associated with advanced interventional ultrasound systems remains a significant barrier to broader adoption, particularly in cost-sensitive and resource-limited environments. High-end ultrasound platforms equipped with AI-driven software and contrast-enhanced imaging features demand substantial capital investment, making them less accessible to smaller clinics or public healthcare institutions. Moreover, procedure-related expenses, including disposable instruments and ongoing maintenance, can further strain healthcare budgets. These cost constraints limit deployment in rural and underserved regions, where access to advanced imaging is already restricted. Addressing these affordability challenges is expected to be crucial to achieving more equitable adoption of interventional ultrasound technology worldwide.

Market Opportunities

Expansion in Emerging Markets: Emerging markets present a substantial growth opportunity for the interventional ultrasound market, driven by rising healthcare investments, improving infrastructure, and increasing awareness of minimally invasive techniques. Countries in Asia-Pacific, Latin America, and the Middle East have been witnessing rapid growth in healthcare expenditure and a growing burden of chronic diseases, creating demand for scalable and cost-effective imaging solutions. Additionally, initiatives by governments and global health organizations to improve access to diagnostic and therapeutic tools are accelerating the adoption of interventional ultrasound systems. Market players expanding their presence through local partnerships, training programs, and region-specific product lines stand to benefit significantly from the untapped potential in these fast-growing economies.

How can this report add value to an organization?

Product/Innovation Strategy: The global interventional ultrasound market has been extensively segmented based on various categories, such as application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: New offerings accounted for the maximum number of key developments, i.e., nearly 58.1% of the total developments in the global interventional ultrasound market were between January 2021 and May 2025.

Competitive Strategy: The global interventional ultrasound market has numerous established players with product portfolios. Key players in the global interventional ultrasound market analyzed and profiled in the study include established players offering products for interventional ultrasound systems.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2022-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report presents a comprehensive market study of the upstream and downstream products in the interventional ultrasound market.
  • The market contribution of interventional ultrasound is anticipated to be launched in the future and has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available interventional ultrasound systems. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research

The primary sources involve industry experts in interventional ultrasound, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players in the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Canon Inc.
  • DeepSight Technology, Inc.
  • Edan Instruments
  • Esaote SPA
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Samsung Healthcare
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • SonoScape Medical Corp.

Table of Contents

Executive Summary

Scope and Definition

1 Global Interventional Ultrasound Market: Industry Outlook

  • 1.1 Key Market Trends
    • 1.1.1 Impact Analysis
    • 1.1.2 Integration of Artificial Intelligence in Ultrasound Systems
    • 1.1.3 Increase in Ultrasound System Product Launch
  • 1.2 Patent Analysis
    • 1.2.1 Patent Filing Trend (by Country)
    • 1.2.2 Patent Filing Trend (by Year)
  • 1.3 Regulatory Landscape
    • 1.3.1 U.S.
    • 1.3.2 Europe
    • 1.3.3 Asia-Pacific
      • 1.3.3.1 China
      • 1.3.3.2 Japan
      • 1.3.3.3 India
      • 1.3.3.4 Australia
  • 1.4 Pricing Analysis
  • 1.5 Market Dynamics
    • 1.5.1 Market Drivers
      • 1.5.1.1 Rising Demand for Minimally Invasive Procedures
      • 1.5.1.2 Growing Prevalence of Chronic Diseases
      • 1.5.1.3 Technological Advancements
    • 1.5.2 Market Challenges
      • 1.5.2.1 High Cost of Equipment and Procedures
      • 1.5.2.2 Shortage of Skilled Professionals
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Expansion in Emerging Markets

2 Global Interventional Ultrasound Market (by Application), ($Million), 2023-2035

  • 2.1 General Surgery
  • 2.2 Cancer
    • 2.2.1 Lung Cancer
    • 2.2.2 Breast Cancer
    • 2.2.3 Liver Cancer
    • 2.2.4 Kidney Cancer
    • 2.2.5 Prostate Cancer
    • 2.2.6 Others
  • 2.3 Cardiac and Endovascular
  • 2.4 Others

3 Global Interventional Ultrasound Market (by End User), ($Million), 2023-2035

  • 3.1 Hospitals and Clinics
  • 3.2 Ambulatory Surgical Centers
  • 3.3 Others

4 Global Interventional Ultrasound Market (by Region), ($Million), 2023-2035

  • 4.1 North America
    • 4.1.1 Regional Overview
    • 4.1.2 Driving Factors for Market Growth
    • 4.1.3 Factors Challenging the Market
    • 4.1.4 Market Sizing and Forecast
      • 4.1.4.1 North America Interventional Ultrasound Market, by Application
      • 4.1.4.2 North America Interventional Ultrasound Market, by End User
      • 4.1.4.3 North America Interventional Ultrasound Market, by Country
        • 4.1.4.3.1 U.S.
          • 4.1.4.3.1.1 Country Overview
          • 4.1.4.3.1.2 Market Sizing and Forecast
          • 4.1.4.3.1.2.1 U.S. Interventional Ultrasound Market, by End User
        • 4.1.4.3.2 Canada
          • 4.1.4.3.2.1 Country Overview
          • 4.1.4.3.2.2 Market Sizing and Forecast
          • 4.1.4.3.2.2.1 Canada Interventional Ultrasound Market, by End User
  • 4.2 Europe
    • 4.2.1 Regional Overview
    • 4.2.2 Driving Factors for Market Growth
    • 4.2.3 Factors Challenging the Market
    • 4.2.4 Market Sizing and Forecast
      • 4.2.4.1 Europe Interventional Ultrasound Market, by Application
      • 4.2.4.2 Europe Interventional Ultrasound Market, by End User
      • 4.2.4.3 Europe Interventional Ultrasound Market, by Country
        • 4.2.4.3.1 U.K.
          • 4.2.4.3.1.1 Country Overview
          • 4.2.4.3.1.2 Market Sizing and Forecast
          • 4.2.4.3.1.2.1 U.K. Interventional Ultrasound Market, by End User
        • 4.2.4.3.2 France
          • 4.2.4.3.2.1 Country Overview
          • 4.2.4.3.2.2 Market Sizing and Forecast
          • 4.2.4.3.2.2.1 France Interventional Ultrasound Market, by End User
        • 4.2.4.3.3 Germany
          • 4.2.4.3.3.1 Country Overview
          • 4.2.4.3.3.2 Market Sizing and Forecast
          • 4.2.4.3.3.2.1 Germany Interventional Ultrasound Market, by End User
        • 4.2.4.3.4 Italy
          • 4.2.4.3.4.1 Country Overview
          • 4.2.4.3.4.2 Market Sizing and Forecast
          • 4.2.4.3.4.2.1 Italy Interventional Ultrasound Market, by End User
        • 4.2.4.3.5 Spain
          • 4.2.4.3.5.1 Country Overview
          • 4.2.4.3.5.2 Market Sizing and Forecast
          • 4.2.4.3.5.2.1 Spain Interventional Ultrasound Market, by End User
        • 4.2.4.3.6 Rest-of-Europe
          • 4.2.4.3.6.1 Country Overview
          • 4.2.4.3.6.2 Market Sizing and Forecast
          • 4.2.4.3.6.3 Rest-of-Europe Interventional Ultrasound Market, by End User
  • 4.3 Asia-Pacific
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Market Sizing and Forecast
      • 4.3.4.1 Asia-Pacific Interventional Ultrasound Market, by Application
      • 4.3.4.2 Asia-Pacific Interventional Ultrasound Market, by End User
      • 4.3.4.3 Asia-Pacific Interventional Ultrasound Market, by Country
        • 4.3.4.3.1 Japan
          • 4.3.4.3.1.1 Country Overview
          • 4.3.4.3.1.2 Market Sizing and Forecast
          • 4.3.4.3.1.2.1 Japan Interventional Ultrasound Market, by End User
        • 4.3.4.3.2 China
          • 4.3.4.3.2.1 Country Overview
          • 4.3.4.3.2.2 Market Sizing and Forecast
          • 4.3.4.3.2.3 China Interventional Ultrasound Market, by End User
        • 4.3.4.3.3 India
          • 4.3.4.3.3.1 Country Overview
          • 4.3.4.3.3.2 Market Sizing and Forecast
          • 4.3.4.3.3.2.1 India Interventional Ultrasound Market, by End User
        • 4.3.4.3.4 Australia
          • 4.3.4.3.4.1 Country Overview
          • 4.3.4.3.4.2 Market Sizing and Forecast
          • 4.3.4.3.4.2.1 Australia Interventional Ultrasound Market, by End User
        • 4.3.4.3.5 South Korea
          • 4.3.4.3.5.1 Country Overview
          • 4.3.4.3.5.2 Market Sizing and Forecast
          • 4.3.4.3.5.2.1 South Korea Interventional Ultrasound Market, by End User
        • 4.3.4.3.6 Rest-of-Asia-Pacific
          • 4.3.4.3.6.1 Country Overview
          • 4.3.4.3.6.2 Market Sizing and Forecast
          • 4.3.4.3.6.2.1 Rest-of-Asia-Pacific Interventional Ultrasound Market, by End User
  • 4.4 Latin America
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Market Sizing and Forecast
      • 4.4.4.1 Latin America Interventional Ultrasound Market, by Application
      • 4.4.4.2 Latin America Interventional Ultrasound Market, by End User
      • 4.4.4.3 Latin America Interventional Ultrasound Market, by Country
        • 4.4.4.3.1 Brazil
          • 4.4.4.3.1.1 Country Overview
          • 4.4.4.3.1.2 Market Sizing and Forecast
          • 4.4.4.3.1.2.1 Brazil Interventional Ultrasound Market, by End User
        • 4.4.4.3.2 Mexico
          • 4.4.4.3.2.1 Country Overview
          • 4.4.4.3.2.2 Market Sizing and Forecast
          • 4.4.4.3.2.3 Mexico Interventional Ultrasound Market, by End User
        • 4.4.4.3.3 Rest-of-Latin America
          • 4.4.4.3.3.1 Country Overview
          • 4.4.4.3.3.2 Market Sizing and Forecast
          • 4.4.4.3.3.2.1 Rest-of-Latin America Interventional Ultrasound Market, by End User
  • 4.5 Middle East and Africa
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 Market Sizing and Forecast
      • 4.5.4.1 Middle East and Africa Interventional Ultrasound Market, by Application
      • 4.5.4.2 Middle East and Africa Interventional Ultrasound Market, by End User

5 Competitive Landscape and Company Profiles

  • 5.1 Competitive Landscape
  • 5.2 Company Profiles
    • 5.2.1 Canon Inc.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products/Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers
      • 5.2.1.5 Key Personal
      • 5.2.1.6 Analyst View
    • 5.2.2 DeepSight Technology, Inc.
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products/Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers
      • 5.2.2.5 Key Personal
      • 5.2.2.6 Analyst View
    • 5.2.3 Edan Instruments
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products/Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers
      • 5.2.3.5 Key Personal
      • 5.2.3.6 Analyst View
    • 5.2.4 Esaote SPA
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products/Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers
      • 5.2.4.5 Key Personal
      • 5.2.4.6 Analyst View
    • 5.2.5 FUJIFILM Holdings Corporation
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products/Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers
      • 5.2.5.5 Key Personal
      • 5.2.5.6 Analyst View
    • 5.2.6 GE HealthCare
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products/Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers
      • 5.2.6.5 Key Personal
      • 5.2.6.6 Analyst View
    • 5.2.7 Konica Minolta, Inc.
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products/Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers
      • 5.2.7.5 Key Personal
      • 5.2.7.6 Analyst View
    • 5.2.8 Koninklijke Philips N.V.
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products/Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers
      • 5.2.8.5 Key Personal
      • 5.2.8.6 Analyst View
    • 5.2.9 Samsung Healthcare
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products/Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers
      • 5.2.9.5 Key Personal
      • 5.2.9.6 Analyst View
    • 5.2.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products/Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers
      • 5.2.10.5 Key Personal
      • 5.2.10.6 Analyst View
    • 5.2.11 Siemens Healthineers AG
      • 5.2.11.1 Overview
      • 5.2.11.2 Top Products/Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Target Customers
      • 5.2.11.5 Key Personal
      • 5.2.11.6 Analyst View
    • 5.2.12 SonoScape Medical Corp.
      • 5.2.12.1 Overview
      • 5.2.12.2 Top Products/Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Target Customers
      • 5.2.12.5 Key Personal
      • 5.2.12.6 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Interventional Ultrasound Market (by Scenario), $Million, 2025, 2029, and 2035
  • Figure 2: Global Interventional Ultrasound Market, 2025 and 2035
  • Figure 3: Top Countries, Global Interventional Ultrasound Market, $Million, 2024
  • Figure 4: Global Interventional Ultrasound Market, $Million, 2025 and 2035
  • Figure 5: Global Interventional Ultrasound Market (by Application), $Million, 2025, 2029, and 2035
  • Figure 6: Global Interventional Ultrasound Market (by End User), in Million, 2025, 2029, and 2035
  • Figure 7: Areas of ML Integration in Ultrasound Systems
  • Figure 8: Number of Patents Files (by Country), January 2021 to May 2025
  • Figure 9: Number of Patents Files (by Year), January 2021 to May 2025
  • Figure 10: Incidence of Cancer (by Region), 2020-2040
  • Figure 11: Volumetric Ultrasound Device
  • Figure 12: Global Interventional Ultrasound Market (by Application), $Million, 2025, 2029, and 2035
  • Figure 13: Global Interventional Ultrasound Market (General Surgery), $Million, 2023-2035
  • Figure 14: Global Interventional Ultrasound Market (Cancer), $Million, 2023-2035
  • Figure 15: Global Interventional Ultrasound Market (Lung Cancer), $Million, 2023-2035
  • Figure 16: Global Interventional Ultrasound Market (Breast Cancer), $Million, 2023-2035
  • Figure 17: Global Interventional Ultrasound Market (Liver Cancer), $Million, 2023-2035
  • Figure 18: Global Interventional Ultrasound Market (Kidney Cancer), $Million, 2023-2035
  • Figure 19: Global Interventional Ultrasound Market (Prostate Cancer), $Million, 2023-2035
  • Figure 20: Global Interventional Ultrasound Market (Other Cancer Types), $Million, 2023-2035
  • Figure 21: Global Interventional Ultrasound Market (Cardiac and Endovascular), $Million, 2023-2035
  • Figure 22: Global Interventional Ultrasound Market (Others), $Million, 2023-2035
  • Figure 23: Global Interventional Ultrasound Market (by End User), $Million, 2025, 2029, and 2035
  • Figure 24: Global Interventional Ultrasound Market (Hospital and Clinics), $Million, 2023-2035
  • Figure 25: Global Interventional Ultrasound Market (Ambulatory Surgical Centers), $Million, 2023-2035
  • Figure 26: Global Interventional Ultrasound Market (Others), $Million, 2023-2035
  • Figure 27: North America Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 28: U.S. Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 29: Canada Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 30: Europe Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 31: U.K. Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 32: France Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 33: Germany Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 34: Italy Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 35: Spain Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 36: Rest-of-Europe Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 37: Asia-Pacific Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 38: Japan Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 39: China Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 40: India Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 41: Australia Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 42: South Korea Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 43: Rest-of-Asia-Pacific Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 44: Latin America Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 45: Brazil Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 46: Mexico Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 47: Rest-of-Latin America Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 48: Middle East and Africa Interventional Ultrasound Market, $Million, 2023-2035
  • Figure 49: Strategic Initiatives, January 2021-May 2025
  • Figure 50: Data Triangulation
  • Figure 51: Top-Down and Bottom-Up Approach
  • Figure 52: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Key Market Trends
  • Table 3: Some of the Ongoing Activity in AI in Ultrasound Systems
  • Table 4: Some of the Recent Product Launches in Interventional Ultrasound Market
  • Table 5: Price of Interventional Ultrasound Systems
  • Table 6: Market Dynamics
  • Table 7: Global Interventional Ultrasound Market (by Region), $Million, 2023-2035
  • Table 8: North America Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 9: North America Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 10: North America Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 11: U.S. Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 12: Canada Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 13: Europe Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 14: Europe Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 15: Europe Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 16: U.K. Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 17: France Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 18: Germany Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 19: Italy Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 20: Spain Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 21: Rest-of-Europe Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 22: Asia-Pacific Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 23: Asia-Pacific Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 24: Asia-Pacific Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 25: Japan Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 26: China Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 27: India Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 28: Australia Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 29: South Korea Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 30: Rest-of-Asia-Pacific Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 31: Latin America Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 32: Latin America Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 33: Latin America Interventional Ultrasound Market (by Country), $Million, 2023-2035
  • Table 34: Brazil Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 35: Mexico Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 36: Rest-of-Latin America Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 37: Middle East and Africa Interventional Ultrasound Market (by Application), $Million, 2023-2035
  • Table 38: Middle East and Africa Interventional Ultrasound Market (by End User), $Million, 2023-2035
  • Table 39: Global Market Share, 2024